...
机译:洞悉接种人HER2 / neu胞外域加上抗HER2 / neu IgG3-(IL-2)或抗HER2 / neu IgG3-(GM-CSF)融合蛋白的小鼠的抗肿瘤免疫机制
Animals; B-Lymphocytes immunology; CD4-Positive T-Lymphocytes immunology; CD8-Positive T-Lymphocytes immunology; Cancer Vaccines immunology; Female; Granulocyte-Macrophage Colony-Stimulating Factor immunology; Humans; Immunoglobulin G immunology; Killer Cells; Natural immunology; Mice; Mice; Inbred BALB C; Receptor; erbB-2 immunology; Recombinant Fusion Proteins immunology; Research Support; N.I.H.; Extramural; Research Support; Non-U.S. Gov't; Research Support; U.S. Gov't; P.H.S.; Vaccination; Vaccines; Synthetic immunology;
机译:洞悉接种人HER2 / neu胞外域加上抗HER2 / neu IgG3-(IL-2)或抗HER2 / neu IgG3-(GM-CSF)融合蛋白的小鼠的抗肿瘤免疫机制
机译:用HER2 / neu胞外域蛋白加上抗HER2 / neu抗体-细胞因子融合蛋白进行蛋白质疫苗接种可在小鼠中诱导保护性抗HER2 / neu免疫反应
机译:用于治疗人HER2 / neu表达肿瘤的重组IgG3-(IL-2)融合蛋白。
机译:用表达来自人乳头瘤病毒16型和18型的二价E7E6融合蛋白的重组牛痘病毒接种的小鼠和恒河猴的免疫原性
机译:靶向IL-2受体用胱天蛋白酶融合蛋白扰乱预脂肪酸和糖尿病Nod小鼠的自身免疫